Tetracaine Hydrochloride Solution/ Drops
NDC Package 82260-920-05
Package Information
Tetracaine Hydrochloride solution/ dropses is tetracaine Hydrochloride Ophthalmic Solution, USP 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. This formulation utilizes a solution/ drops delivery system. Marketed by Bausch & Lomb Americas Inc., this product is identified by NDC 82260-920 and is authorized under FDA application NDA210821.
Identification & Billing
- RxCUI: 1547771 - tetracaine HCl 0.5 % Ophthalmic Solution
- RxCUI: 1547771 - tetracaine hydrochloride 5 MG/ML Ophthalmic Solution
- RxCUI: 1547771 - tetracaine hydrochloride 0.5 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82260 - Bausch & Lomb Americas Inc.
- 82260-920 - Tetracaine Hydrochloride
- 82260-920-05 - 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER
- 82260-920 - Tetracaine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (82260-920). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82260-920-05 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 5 ml in 1 bottle, dropper of Tetracaine Hydrochloride, a human prescription drug labeled by Bausch & Lomb Americas Inc.. This solution/ drops is formulated for ophthalmic use and contains tetracaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Americas Inc. on September 21, 2022. The current certification is valid through December 31, 2027.
How is this Bausch & Lomb Americas Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82260092005. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.